68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of 68Ga-OPS202 used for
the diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP NETs).